SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-16-013789
Filing Date
2016-09-23
Accepted
2016-09-23 16:16:20
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 d91816010q.htm 10-Q 563061
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 94923
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 17113
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 7850
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7913
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5326
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 4652
  Complete submission text file 0001214659-16-013789.txt   3542119

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kbio-20160331.xml EX-101.INS 644859
9 XBRL TAXONOMY EXTENSION SCHEMA kbio-20160331.xsd EX-101.SCH 37509
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kbio-20160331_cal.xml EX-101.CAL 45464
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kbio-20160331_def.xml EX-101.DEF 167426
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kbio-20160331_lab.xml EX-101.LAB 348627
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kbio-20160331_pre.xml EX-101.PRE 232495
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 161899977
SIC: 2834 Pharmaceutical Preparations